Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vacuolar protein sorting-associated protein 34 (VPS34) is the only known member of the class III phosphoinositide 3‑kinases. It functions as a lipid kinase that phosphorylates phosphatidylinositol to generate phosphatidylinositol 3-phosphate [PtdIns(3)P], a crucial signaling molecule involved in membrane trafficking events such as endocytosis, autophagy initiation, and lysosomal/vacuolar function. VPS34 forms multi-protein complexes with regulatory subunits to mediate distinct cellular processes—most notably autophagosome nucleation and endosomal sorting. Its activity is essential for normal cell homeostasis; dysregulation has been linked to diseases including cancer and viral infections due to its central role in controlling intracellular degradation pathways.
Inhibition of VPS34 blocks the formation of PtdIns(3)P, thereby disrupting autophagosome formation and endosomal trafficking. This can suppress cellular processes like autophagy that are critical for cell survival under stress or infection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vacuolar protein sorting-associated protein 34 (VPS34).